ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HSIC vs OSCR // NET PROFIT MARGIN

Henry Schein Inc. (NASDAQ) VS. Oscar Health Inc. (NYSE) • 15-METRIC TALLY: HSIC 8 — OSCR 3
▲ NET PROFIT MARGIN LEADER: HSIC
net-margins
3.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HSIC VS. OSCR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HSIC OSCR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 31.10% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 11.20% -35.00% +46.20 HSIC /roic <GO>
EV/EBITDA & P/E Valuation 9.5x — — TIE /valuation <GO>
Free Cash Flow Yield 1.23% 11.51% -10.28 OSCR /fcf-yield <GO>
Operating Margin 5.00% -60.00% +65.00 HSIC /operating-margins <GO>
Net Profit Margin ACTIVE 3.20% -60.00% +63.20 HSIC /net-margins <GO>
Revenue Growth (YoY) 4.00% 39.00% -35.00 OSCR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.81 0.45 +2.36 HSIC /balance-sheet <GO>
Piotroski F-Score Quality 7/9 6/9 +1.00 HSIC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 47.5 41.9 +5.60 HSIC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.89 0.97 -0.08 OSCR /macro-sensitivity <GO>
Forward P/E Multiple 21.4x 23.0x -1.60 HSIC /forward-pe <GO>
Enterprise Scale & Market Cap $9.46B $9.37B $86.0M HSIC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HSIC REV OSCR REV HSIC GROSS % OSCR GROSS % HSIC FCF OSCR FCF
FY 2025 $13.18B $28.6M 31.1% — $118.7M $1.09B
FY 2024 $12.67B $20.6M 31.7% — $277.7M $977.3M
FY 2023 $12.34B $21.4M — — -$55.3M -$273.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HSIC // BETA 0.89
OSCR // BETA 0.97